Neovasc Investor Relations Material
Latest events
Q3 2022
Neovasc
Q4 2022
31 Mar, 2023
Corporate Strategy Update
11 Nov, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Neovasc Inc
Access all reports
Neovasc Inc. is a medical device company that focuses on the development of products for the treatment of cardiovascular diseases. The company's primary offerings include devices designed to address refractory angina, a chronic condition characterized by chest pain, and to support heart valve repair procedures. The company is headquartered in Richmond, Canada, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NVCN
Country
🇨🇦 Canada